NCT06352671 Prospective Long-Term Outcomes of a Standardized Ross Procedure
| NCT ID | NCT06352671 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Aortic Valve Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 225 participants |
| Start Date | 2023-10-12 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 225 participants in total. It began in 2023-10-12 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing Ross procedure at Baylor Scott and White The Heart Hospital, Plano, The University of Pennsylvania, The University of Washington, and Northwestern University. Exclusion Criteria: * Less than 18 years of age * Presence of active malignancy * Pregnant at the time of surgery * Inability to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06352671 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Aortic Valve Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06352671 currently recruiting?
Yes, NCT06352671 is actively recruiting participants. Contact the research team at Bonnie.Ostergren@BSWHealth.org for enrollment information.
Where is the NCT06352671 trial being conducted?
This trial is being conducted at Plano, United States.
Who is sponsoring the NCT06352671 clinical trial?
NCT06352671 is sponsored by Baylor Research Institute. The trial plans to enroll 225 participants.